Orforglipron In phase II, randomized, double-blind study, adults with overweight or obesity and without T2DM who took oral orforglipron (12, 24, 36, or 45 mg) daily for 36 weeks experienced a weight reduction of 9.414.7% [105]
Thymosin beta-4 and wound healing: Clinical and experimental perspectives
Sermorelin is our most commonly prescribed GH secretagogue and is detailed on our sermorelin therapy page
At position fifteen, the amino acid histidine (His) is replaced with a modified amino acid called D-Phenylalanine (D-Phe)
BPC-157 BPC-157, or Body Protection Compound 157, is a derivative of the BPC protein naturally found in the human digestive tract
The 2025 NEJM trial comparing tirzepatide directly against semaglutide showed 20.2% versus 13.7% weight loss over the same treatment period